Difference between revisions of "Part:BBa K2235010"

Revision as of 09:42, 28 October 2017

Endo beta galactosidase with T7 promoter, RBS and functional unit

Introduction

BBa_K2235010 biobrick is a composite of a T7 promoter and RBS followed by endo-β-galactosidase enzyme coding site which is N-terminally attached to a His-tag. This enzyme has been shown to release saccharide chains from glycans expressed in gastric mucus. It performs this action by hydrolysing the bonds next to galactose saccharides in the polysaccharide chains of mucins. The sequence originates from the species Clostridium Perfringens. The basic part BBa_K2235008 consists of the endo beta galactosidase enzyme coding sequence with a His-tag N-terminally attached.

Usage and Biology

The endo-β-galactosidase (Endo-β-GalGnGa) was originally expressed from Clostridium perfringens. This bacteria strain is capable of releasing GlcNAcα1→4Gal from glycans expressed in the gastric mucous cell-type mucin [1]. This enzyme specifically releases the disaccharide GlcNAcR1f 4Gal from O-glycans expressed in the gastric gland mucous cell-type mucin. This enzyme has been shown to hydrolyze the endo-â-galactosyl linkage not only in the GlcNAcR1f 4Galâ1f4GlcNAc sequence but also in GlcNAcR1f 4Galâ1f3GalNAcR1fSer/Thr. Endo-â-GalGnGa is distinct from the hitherto known endo-â-galactosidases because of its strict specificity for releasing the disaccharide GlcNAcR1f 4Gal. To characterize Endo-â-GalGnGa, we have carried out the molecular cloning of this endoglycosidase. Here we describe the cloning, characterization, and overexpression of the gene encoding Endo-â-GalGnGa and the hypothesis testing of degrading mucus.

Characterizations

Important Parameters

Purification and Identification of EBG

EBG Enzymatic Activity on Mucin

To determine the concentration of sugars after the EBG digestion of PGM a colorimetric assay was performed. Industrially available EBG was used firstly to test the assay. The results from the assay were inconclusive as a result of a strong response from the negative control.

Due to time restraints this part of the project was never completed. The next step after fixing the assay would have been to test the expressed EBG from E. coli.

Methods

Reference

1. Ashida, H., Anderson, K., Nakayama, J., Maskos, K., Chou, C.-W., Cole, R. B., Li, S.-C., and Li, Y.-T. (2001) J. Biol. Chem. 276, 28226−28232

Sequence and Features